Top

Published in:

01-04-2014 | Research Article

Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn’s disease patients

Authors: Lars E. Bartels, Mia Bendix, Christian L. Hvas, Søren P. Jørgensen, Jørgen Agnholt, Ralf Agger, Jens F. Dahlerup

Published in: Inflammopharmacology | Issue 2/2014

Abstract

Background

Low serum vitamin D levels may provoke or aggravate Crohn’s disease (CrD). Vitamin D3 is a well-known immune modulator that affects immune functions in vitro and may prevent CrD flares. Dendritic cells (DC) are key mediators of vitamin D3 effects. In this study, we describe changes in monocyte-derived DC (mo-DC) maturation marker expression and cytokine production following 26 weeks of oral vitamin D3 supplementation in CrD patients.

Methods

Ten CrD patients who had increased serum 25-hydroxy vitamin D levels after oral vitamin D3 and calcium treatment and ten seasonally matched placebo-treated patients were selected for this study. Mo-DC were generated before and after the 26 weeks and induced to mature upon lipopolysaccharide (LPS) stimulation. Maturation marker expression and cytokine production were analysed. Mo-DC function was analysed in a mixed leucocyte reaction (MLR).

Results

Compared with baseline values, LPS-matured mo-DC exhibited reduced expression of CD80 and reduced production of the cytokines IL-10, IL-1β, and IL-6 following 26 weeks of oral vitamin D3 supplementation. Mo-DC performance in an allogeneic MLR was unchanged after vitamin D3 supplementation. Treatment with the placebo did not affect maturation markers, cytokine production, or the MLR.

Conclusions

Vitamin D3 treatment in CrD patients led to hypo-responsive LPS-stimulated mo-DC. This finding indicates that vitamin D3 levels have an impact on the monocytic precursors of mo-DC in vivo and may explain the positive effects of vitamin D3 supplementation on CrD patients. Alternatively, CrD patients with high serum vitamin D3 levels may represent a subgroup with low disease activity.

Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361:2066–2078PubMedCentralPubMedCrossRef

Abreu MT, Kantorovich V, Vasiliauskas EA, Gruntmanis U, Matuk R, Daigle K, Chen S, Zehnder D, Lin YC, Yang H, Hewison M, Adams JS (2004) Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut 53:1129–1136PubMedCentralPubMedCrossRef

Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, Borregaard N, Modlin RL, Hewison M (2009) Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 182:4289–4295PubMedCentralPubMedCrossRef

Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT (2012) Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology 3:482–489CrossRef

Bartels LE, Hvas CL, Agnholt J, Dahlerup JF, Agger R (2010) Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation. Int Immunopharmacol 10:922–928PubMedCrossRef

Bartels LE, Jorgensen SP, Bendix M, Hvas CL, Agnholt J, Agger R, Dahlerup JF (2013) 25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn’s disease. Inflammopharmacology 2:177–186CrossRef

Baumgart DC, Metzke D, Schmitz J, Scheffold A, Sturm A, Wiedenmann B, Dignass AU (2005) Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 54:228–236PubMedCentralPubMedCrossRef

Baumgart DC, Thomas S, Przesdzing I, Metzke D, Bielecki C, Lehmann SM, Lehnardt S, Dorffel Y, Sturm A, Scheffold A, Schmitz J, Radbruch A (2009) Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease. Clin Exp Immunol 157:423–436PubMedCentralPubMedCrossRef

Bendix-Struve M, Bartels LE, Agnholt J, Dige A, Jorgensen SP, Dahlerup JF (2010) Vitamin D3 treatment of Crohn’s disease patients increases stimulated T cell IL-6 production and proliferation. Aliment Pharmacol Ther 32:1364–1372PubMedCrossRef

Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M (2003) Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha, 25-dihydroxyvitamin D3 by human dendritic cells. Blood 102:3314–3316PubMedCrossRef

Hart AL, Al Hassi HO, Rigby RJ, Bell SJ, Emmanuel AV, Knight SC, Kamm MA, Stagg AJ (2005) Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129:50–65PubMedCrossRef

Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, Liu P, Modlin RL, Adams JS (2007) Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103:316–321PubMedCrossRef

Jorgensen SP, Agnholt J, Glerup H, Lyhne S, Villadsen GE, Hvas CL, Bartels LE, Kelsen J, Christensen LA, Dahlerup JF (2010) Clinical trial: vitamin D3 treatment in Crohn’s disease—a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 32:377–383PubMedCrossRef

Jorgensen SP, Hvas CL, Agnholt J, Christensen LA, Heickendorff L, Dahlerup JF (2013) Active Crohn’s disease is associated with low vitamin D levels. J Crohn’s Colitis 7:e407–e413

Joseph AJ, George B, Pulimood AB, Seshadri MS, Chacko A (2009) 25 (OH) vitamin D level in Crohn’s disease: association with sun exposure & disease activity. Indian J Med Res 130:133–137PubMed

Kelly P, Suibhne TN, O’Morain C, O’Sullivan M (2011) Vitamin D status and cytokine levels in patients with Crohn’s disease. Int J Vitam Nutr Res 4:205–210CrossRef

Liu PT, Stenger S, Tang DH, Modlin RL (2007) Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 179:2060–2063PubMed

Middel P, Raddatz D, Gunawan B, Haller F, Radzun HJ (2006) Increased number of mature dendritic cells in Crohn’s disease: evidence for a chemokine mediated retention mechanism. Gut 55:220–227PubMedCentralPubMedCrossRef

Nerich V, Monnet E, Etienne A, Louafi S, Ramee C, Rican S, Weill A, Vallier N, Vanbockstael V, Auleley GR, Allemand H, Carbonnel F (2006) Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 12:218–226PubMedCrossRef

Niess JH (2008) Role of mucosal dendritic cells in inflammatory bowel disease. World J Gastroenterol 14:5138–5148PubMedCentralPubMedCrossRef

Niessner M, Volk BA (1995) Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 101:428–435PubMedCentralPubMedCrossRef

Pedersen AW, Holmstrom K, Jensen SS, Fuchs D, Rasmussen S, Kvistborg P, Claesson MH, Zocca MB (2009) Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin Exp Immunol 157:48–59PubMedCentralPubMedCrossRef

Penna G, Adorini L (2000) 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405–2411PubMed

Penna G, Roncari A, Amuchastegui S, Daniel KC, Berti E, Colonna M, Adorini L (2005) Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 106:3490–3497PubMedCrossRef

Salucci V, Rimoldi M, Penati C, Sampietro GM, van Duist MM, Matteoli G, Saibeni S, Vecchi M, Ardizzone S, Porro GB, Rescigno M (2008) Monocyte-derived dendritic cells from Crohn patients show differential NOD2/CARD15-dependent immune responses to bacteria. Inflamm Bowel Dis 14:812–818PubMedCrossRef

Shanahan F, Bernstein CN (2009) The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 25:301–305PubMedCrossRef

Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39:690–697PubMedCentralPubMedCrossRef

Siffledeen JS, Siminoski K, Steinhart H, Greenberg G, Fedorak RN (2003) The frequency of vitamin D deficiency in adults with Crohn’s disease. Can J Gastroenterol 17:473–478PubMed

Tang J, Zhou R, Luger D, Zhu W, Silver PB, Grajewski RS, Su SB, Chan CC, Adorini L, Caspi RR (2009) Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 182:4624–4632PubMedCentralPubMedCrossRef

Te Velde AA, van Kooyk Y, Braat H, Hommes DW, Dellemijn TA, Slors JF, Van Deventer SJ, Vyth-Dreese FA (2003) Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn’s disease. Eur J Immunol 33:143–151CrossRef

Tuohy KA, Steinman TI (2005) Hypercalcemia due to excess 1,25-dihydroxyvitamin D in Crohn’s disease. Am J Kidney Dis 45:e3–e6PubMedCrossRef

Varol C, Landsman L, Fogg DK, Greenshtein L, Gildor B, Margalit R, Kalchenko V, Geissmann F, Jung S (2007) Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med 204:171–180PubMedCentralPubMedCrossRef

Varol C, Vallon-Eberhard A, Elinav E, Aychek T, Shapira Y, Luche H, Fehling HJ, Hardt WD, Shakhar G, Jung S (2009) Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31:502–512PubMedCrossRef

Vuckovic S, Florin TH, Khalil D, Zhang MF, Patel K, Hamilton I, Hart DN (2001) CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases. Am J Gastroenterol 96:2946–2956PubMedCrossRef

Wolters FL, Joling C, Russel MG, Sijbrandij J, De BM, Odes S, Riis L, Munkholm P, Bodini P, Ryan B, O’Morain C, Mouzas IA, Tsianos E, Vermeire S, Monteiro E, Limonard C, Vatn M, Fornaciari G, Rodriguez D, Groot W, Moum B, Stockbrugger RW (2007) Treatment inferred disease severity in Crohn’s disease: evidence for a European gradient of disease course. Scand J Gastroenterol 42:333–344PubMedCrossRef

Zeng L, Anderson FH (1996) Seasonal change in the exacerbations of Crohn’s disease. Scand J Gastroenterol 31:79–82PubMedCrossRef

Title: Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn’s disease patients
Authors: Lars E. Bartels
Mia Bendix
Christian L. Hvas
Søren P. Jørgensen
Jørgen Agnholt
Ralf Agger
Jens F. Dahlerup
Publication date: 01-04-2014
Publisher: Springer Basel
Published in: Inflammopharmacology / Issue 2/2014
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-013-0197-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn’s disease patients

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2014

Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis

Analgesic and antiinflammatory activities of the ethyl acetate fraction of Bidens pilosa (Asteraceae)

Endocellular regulation by free radicals and hydrogen peroxide: key determinants of the inflammatory response

Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain

Croton antisyphiliticus Mart. attenuates the inflammatory response to carrageenan-induced pleurisy in mice

Emodin elicits cytotoxicity in human lung adenocarcinoma A549 cells through inducing apoptosis